Patients scheduled for gastrointestinal endoscopy
Conditions
Interventions
group A:Patients in group A were given the investigational drugs alfentanil, remazolam tosylate, and propofol according to the trial protocol.
group B:Patients in group B were given the investigational drugs alfentanil, and propofol according to the trial protocol.
Sponsors
People 's Hospital Of Ningjin
Eligibility
Sex/Gender
All
Age
65 Years to 79 Years
Inclusion criteria
Inclusion criteria: (1) Patients scheduled for gastrointestinal endoscopy; (2) American Society of Anesthesiologists (ASA) physical status I to III; (3) Patients over 65 years of age (including 65 years of age); (4) Patients voluntarily participated in this study and signed informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients who refused to participate in the trial; (2) Patients with a history of severe heart, brain, lung, liver, kidney and metabolic diseases; (3) Patients with a history of abnormal surgical anesthesia recovery; (4) Electrocardiogram showed heart rate 180 mmHg and/or diastolic blood pressure > 110 mmHg, or patients with hypotension < 90/60 mmHg; (7) Patients with neuromuscular system diseases and mental illness; (8) Patients with anemia; (9) Suspected abuse of narcotic analgesics or sedatives; (10) Patients who are predicted to have or have had difficult airways; (11) Patients who are uncooperative and unable to communicate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Systolic blood pressure;Diastolic;Heart Rate;Respiratory rate;Oxygen saturation;Bispectral index; | — |
Secondary
| Measure | Time frame |
|---|---|
| Anesthesia induction time;Total inspection time;Emergence time;Patient Satisfaction Score; | — |
Countries
China
Contacts
Public ContactLei Gaofeng
People 's Hospital Of Ningjin
Outcome results
None listed